ASAM 2.1 IOP Authorization Software
for Kipu EMR
CriteriaIQ automates ASAM Level 2.1 Intensive Outpatient Program authorization inside Kipu EMR. IOP requires documenting why 9+ structured hours per week is needed when standard weekly outpatient (1.0) is insufficient. CriteriaIQ cites PAWS, readiness to change, failed outpatient history, and BAM-R risk scores to build the justification — automatically from the Kipu chart.
9+ structured hours/week. The justification is "why not outpatient?"
IOP is the most common step-down from residential and PHP. The clinical challenge is not justifying that the patient needs treatment — it is documenting why once-weekly standard outpatient is clinically insufficient for this patient at this time.
IOP authorization probability with an IOP-calibrated point system
IOP auth probability is driven by readiness to change, mild-moderate psychiatric symptoms, and PAWS — not by the high-severity withdrawal and psychiatric ratings that drive residential authorization. The rubric reflects this difference.
Post-Acute Withdrawal Syndrome is a specific IOP indicator
PAWS can persist for weeks to months after acute withdrawal. Symptoms — insomnia, cognitive fog, irritability, cravings, mood instability — directly impair a patient's ability to maintain recovery without structured support. This is exactly the clinical scenario IOP is designed for.
CriteriaIQ scans all progress notes, nursing notes, and psychiatry notes for both explicit PAWS documentation and implicit symptom clusters, adds +8 points to IOP auth probability when found, and generates a specific clinical justification explaining why PAWS-related impairments make weekly outpatient insufficient.
Sleep disturbance / insomnia · Cognitive fog / poor concentration · Irritability / mood instability · Cravings / urges · Fatigue / low energy · Anxiety (beyond acute withdrawal) · Anhedonia
IOP authorization in under 60 seconds
Starter plan: $149/seat/month. Enterprise facility rate: $699/month for up to 15 seats. 14-day free trial, no card required.